All Children’s Hospital Los Angeles locations are open.
Emotional Support Phone Line for Current Patients, Families and Team Members:
323-361-1121 (no texts)
8 a.m. - 7 p.m.
Red blood cell disorders, including anemia, sickle cell disease and thalassemia, can affect your child’s health and development. Most of these conditions are rare, which is why it’s important to seek treatment from an experienced care team. This is precisely what you’ll find at Children’s Hospital Los Angeles.
We are home to one of the largest erythrocyte (red blood cell) disorder programs in California. And CHLA is among few centers nationwide that have received federal funding for thalassemia care. Your child benefits from internationally recognized specialists and innovative treatments. Our personalized approach helps more children have an excellent quality of life.
As a large center, we offer a depth of experience with rare and complex erythrocyte disorders that’s not widely available. We build lasting relationships with children and their families that often start when the children are newborns. Our team is meticulous in tailoring therapies as your child gets older or has changing needs. These are some of the many reasons families choose CHLA.
As part of CHLA’s internationally recognized Hematology program, our Red Blood Cell Disorders Program offers:
Red blood cells (erythrocytes) transport oxygen throughout the body. Hemoglobin, a protein inside red blood cells, helps with this action. Red blood cell disorders interfere with this process.
Red blood cell disorders may cause issues with:
A team of specialists guides every step of your child’s care. Your child may see multiple members of our team in one visit, helping them get the most out of each appointment. This team of specialists coordinates ongoing treatment that addresses your child's evolving needs.
In addition to a hematologist, our team includes a:
Types of red blood cell disorders we treat include:
We are advancing care for red blood cell disorders through research. Our interests include new approaches to evaluating blood flow and nervous system issues in children with sickle cell disease. Researchers have also made significant breakthroughs in measuring and treating iron overload disorder. Your child may be able to participate in these efforts through clinical trials.
Explore our research and clinical trials.
The Cancer and Blood Disease Institute welcomes new patients, referrals and second opinions. Please call us to make an appointment.